Literature DB >> 26342055

One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry.

Stephanie J Marin1, Kelly Doyle2, Annie Chang3, Marta Concheiro-Guisan4, Marilyn A Huestis5, Kamisha L Johnson-Davis2.   

Abstract

Some amphetamine (AMP) and ecstacy (MDMA) urine immunoassay (IA) kits are prone to false-positive results due to poor specificity of the antibody. We employed two techniques, high-resolution mass spectrometry (HRMS) and an in silico structure search, to identify compounds likely to cause false-positive results. Hundred false-positive IA specimens for AMP and/or MDMA were analyzed by an Agilent 6230 time-of-flight (TOF) mass spectrometer. Separately, SciFinder (Chemical Abstracts) was used as an in silico structure search to generate a library of compounds that are known to cross-react with AMP/MDMA IAs. Chemical formulas and exact masses of 145 structures were then compared against masses identified by TOF. Compounds known to have cross-reactivity with the IAs were identified in the structure-based search. The chemical formulas and exact masses of 145 structures (of 20 chemical formulas) were compared against masses identified by TOF. Urine analysis by HRMS correlates accurate mass with chemical formulae, but provides little information regarding compound structure. Structural data of targeted antigens can be utilized to correlate HRMS-derived chemical formulas with structural analogs.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26342055      PMCID: PMC4731401          DOI: 10.1093/jat/bkv101

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  15 in total

1.  Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine.

Authors:  Barry K Logan; Anthony G Costantino; Eric F Rieders; David Sanders
Journal:  J Anal Toxicol       Date:  2010-11       Impact factor: 3.367

2.  Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS.

Authors:  Stephanie J Marin; John M Hughes; Bryan G Lawlor; Chantry J Clark; Gwendolyn A McMillin
Journal:  J Anal Toxicol       Date:  2012-07-15       Impact factor: 3.367

3.  The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results.

Authors:  Jason M Baron; David A Griggs; Andrea L Nixon; William H Long; James G Flood
Journal:  J Anal Toxicol       Date:  2011-07       Impact factor: 3.367

4.  False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate.

Authors:  Yusuf Cem Kaplan; Almla Erol; Barş Karadaş
Journal:  Ther Drug Monit       Date:  2012-10       Impact factor: 3.681

5.  Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay.

Authors:  Erica R Casey; Mitchell G Scott; Schirin Tang; Michael E Mullins
Journal:  J Med Toxicol       Date:  2011-06

6.  False-positive amphetamine toxicology screen results in three pregnant women using labetalol.

Authors:  Lynn M Yee; Danny Wu
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

7.  Dimethylamylamine: a drug causing positive immunoassay results for amphetamines.

Authors:  Shawn P Vorce; Justin M Holler; Brian M Cawrse; Joseph Magluilo
Journal:  J Anal Toxicol       Date:  2011-04       Impact factor: 3.367

8.  Crossreactivity of bupropion metabolite with enzyme-linked immunosorbent assays designed to detect amphetamine in urine.

Authors:  Lisa Reidy; H Chip Walls; Bernard W Steele
Journal:  Ther Drug Monit       Date:  2011-06       Impact factor: 3.681

9.  Immunoassay cross-reactivity of phenylephrine and methamphetamine.

Authors:  Lindsay B Curtin; Michael J Cawley
Journal:  Pharmacotherapy       Date:  2012-04-12       Impact factor: 4.705

10.  Digoxin immunoassay with cross-reactivity of digoxin metabolites proportional to their biological activity.

Authors:  J J Miller; R W Straub; R Valdes
Journal:  Clin Chem       Date:  1994-10       Impact factor: 8.327

View more
  2 in total

1.  Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health Records.

Authors:  Jacob J Hughey; Jennifer M Colby
Journal:  Clin Chem       Date:  2019-10-02       Impact factor: 12.167

2.  A Molecularly Imprinted Polymer-based Dye Displacement Assay for the Rapid Visual Detection of Amphetamine in Urine.

Authors:  Joseph W Lowdon; Kasper Eersels; Rocio Arreguin-Campos; Manlio Caldara; Benjamin Heidt; Renato Rogosic; Kathia L Jimenez-Monroy; Thomas J Cleij; Hanne Diliën; Bart van Grinsven
Journal:  Molecules       Date:  2020-11-10       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.